Industry Update: Interim 503A and 503B Bulks Lists New Revisions The FDA reclassified the peptide CJC Ipamorelin so most compounding pharmacies can no longer produce it. While some pharmacies may choose not to comply with the new regulations, we avoid using those Ipamorelin Peptide Growth Hormone Research Compound RNK Health Sermorelin 2026: The Subscription Fine Print, Refund Policy, and FDA History That Most Reviews Leave Out Newswire BPC 157 and ipamorelin under FDA scrutiny Alex Keoskey posted on the topic LinkedIn What Is BPC 157? A Medical Clinic's Guide to the Body Protective Peptide, Its Uses, and What It Actually Does Perfect B